Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 01 tags : Europe save search
The European Wax Center, Inc. to Report Second Quarter 2021 Financial Results on September 14th
Published: 2021-09-01 (Crawled : 20:00) - globenewswire.com
EWCZ | News | $11.595 -1.65% -1.68% 360K
|
|
| O: -1.02%
H: 1.91%
C: -2.5%
financial results europe results
Daré Bioscience to Present at the 13th European Congress on Menopause and Andropause
Published: 2021-09-01 (Crawled : 17:00) - biospace.com/
DARE | $0.2843 -4.37% -4.57% 400K
|
Health Technology
|
| O: 0.0%
H: 1.14%
C: 0.0%
europe drop bioscience
Nemaura Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
Published: 2021-09-01 (Crawled : 16:00) - biospace.com/
NMRD | $0.06 -28.78% 120K
|
Health Technology
|
| O: 1.29%
H: 10.03%
C: 7.91%
conference
Smith+Nephew to expand Real Intelligence digital ecosystem and CORI™ Surgical System with total hip arthroplasty
Published: 2021-09-01 (Crawled : 14:00) - biospace.com/
SNN | $24.57 -0.93% 0.0% 1.2M
|
Health Technology
|
| O: 1.98%
H: 0.22%
C: -0.03%
Silence Therapeutics Appoints Dr. John Strafford as Senior Vice President, Business Development, Alliance Management and New Product Development
Published: 2021-09-01 (Crawled : 14:00) - biospace.com/
SLN | $22.33 -0.8% -0.81% 110K
|
Health Technology
|
| O: -0.0%
H: 0.65%
C: -2.16%
ford new product
Smith+Nephew introduces pioneering new technologies for its JOURNEY™ II total knee arthroplasty portfolio
Published: 2021-09-01 (Crawled : 14:00) - biospace.com/
SNN | $24.57 -0.93% 0.0% 1.2M
|
Health Technology
|
| O: 1.98%
H: 0.22%
C: -0.03%
Ayala Pharmaceuticals to Present Clinical Data from Ongoing Phase 2 ACCURACY Trial and New Preclinical Results from Combination Study of AL101 at the European Society for Medical Oncology (ESMO) Virtual Congress 2021
Published: 2021-09-01 (Crawled : 12:15) - globenewswire.com
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.64%
H: 0.0%
C: -2.2%
AYLA | $0.5036 5.84% -0.7% 0
|
Health Technology
|
| O: -2.6%
H: 6.97%
C: 6.81%
phase 2 europe ongoing results trial preclinical pre-clinical
36Kr Taps into European and Australia & New Zealand Markets
Published: 2021-09-01 (Crawled : 12:00) - prnewswire.com
KRKR | $0.377 -4.36% 1.8K
|
Technology Services
|
| O: 3.01%
H: 8.77%
C: 4.68%
europe
Orchard Therapeutics to Present at Multiple Investor Conferences in September 2021
Published: 2021-09-01 (Crawled : 12:00) - biospace.com/
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: 0.11%
H: 0.52%
C: -0.22%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.52%
H: 11.71%
C: 10.28%
conference
Autolus Therapeutics announces publication of obe-cel (AUTO1) Phase 1 ALLCAR19 data in adults with relapsed/ refractory B-ALL in Journal of Clinical Oncology
Published: 2021-09-01 (Crawled : 12:00) - biospace.com/
AUTL | $4.23 -5.58% -5.91% 2.7M
|
Health Technology
|
| O: 0.44%
H: 6.38%
C: 3.62%
phase 1 cel
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.